A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
After several examples of undisclosed alterations in reagent suppliers’ antibody catalogues surfaced, researchers call for transparency to rebuild trust.
bDanish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital-Rigshospitalet, Glostrup, Denmark cDepartment of Neurology and Center of Clinical Neuroscience, First Faculty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results